Welcome to Aetos Life Care. Looking for a reliable pharmaceutical manufacturer?

Vildagliptin Tablets 50mg

Vildagliptin is a DPP-4 inhibitor used for the treatment of Type 2 Diabetes Mellitus. It works by enhancing incretin hormone activity, leading to improved insulin secretion and reduced glucagon levels. This results in better blood sugar control without causing weight gain.

Category:
QUICK INQUIRY NOW

Description

Mechanism of Action:

✔ Inhibits DPP-4 enzyme, increasing GLP-1 and GIP hormone levels.
Enhances insulin secretion in response to meals.
Reduces glucagon secretion, preventing excess glucose production.

Indications:

✔ Type 2 Diabetes Mellitus
✔ Can be used as monotherapy or in combination with metformin, sulfonylureas, or insulin

Key Benefits:

Does not cause weight gain
Improves postprandial blood sugar control
Low risk of hypoglycemia

Dosage & Administration:

  • Recommended Dosage: 50 mg once or twice daily (as prescribed).
  • Route of Administration: Oral
  • Food Intake: Can be taken with or without food.

Precautions & Warnings:

  • Not recommended in patients with severe liver disease.
  • Monitor kidney function in elderly patients.
  • May cause joint pain or allergic reactions in rare cases.

Possible Side Effects:

  • Mild headache
  • Nausea
  • Hypoglycemia (when combined with other antidiabetic drugs)

Storage & Packaging:

  • Store below 30°C in a cool, dry place.
  • Available in blister packs and bulk packaging.

Manufacturing & Regulatory Compliance:

Manufactured by Aetos Life Care in WHO-GMP certified facilities, ensuring compliance with EU-GMP standards.

Global Export & Supply:

Aetos Life Care exports Vildagliptin Tablets 50 mg to Latin America, Africa, Asia, Europe, and CIS countries, providing high-quality and affordable diabetes care worldwide.

Leading Manufacturer and Exporter of Pharmaceuticals Across Continents

Aetos Life Care is a trusted manufacturer and exporter of high-quality generic and specialty medicines, serving over 40 countries across Latin America, Africa, Asia, Europe, and the CIS region. We have a strong presence in key markets, including Iraq, Jordan, Saudi Arabia, UAE, Ukraine, Kazakhstan, Venezuela, Ecuador, and more. Backed by 15 WHO-GMP accredited facilities designed to meet EU-GMP standards, we ensure the highest quality, safety, and compliance in every product we deliver.

Iraq, Jordan, Riyadh (Saudi Arabia), Dubai (UAE)

Ukraine, Kazakhstan, Turkmenistan, Tajikistan

Venezuela, Ecuador, Peru, Paraguay, Panama, Costa Rica, El Salvador

Cameroon, South Sudan, Angola

Myanmar